See also this year's filing and all EDGAR filings for this company.
PDF Report 0001131324_2015_Genomic_Health_INC.pdf
Logs
warning | The stock price does not exist | industry.us_generic | {} |
warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
warning | No stock price available | subcommand.plot | {} |
info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131324')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131324')"} |
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001131324, Genomic Health INC
xvar | xval | |
---|---|---|
0 | IntangibleAssets | 0 |
1 | AssetsNonCurrent | 15,541,000 |
2 | AssetsCurrent | 148,520,000 |
3 | PropertyPlantAndEquipment | 21,860,000 |
4 | remainder_Assets | 0 |
5 | LongTermLiabilities | 0 |
6 | LiabilitiesCurrent | 38,338,000 |
7 | remainder_Liabilities | 0 |
8 | LaborExpense | 0 |
9 | CostOfGoodsAndServicesSold | 0 |
10 | GeneralAndAdministrativeExpense | 59,669,000 |
11 | GoodwillImpairmentLoss | 0 |
12 | OperatingCostsAndExpenses | 0 |
13 | DepreciationDepletionAndAmortization | 0 |
14 | SellingAndMarketingExpense | 134,858,000 |
15 | ResearchAndDevelopmentExpense | 56,064,000 |
16 | remainder_Expenses | 49,135,000 |
17 | remainder_Revenues | 275,706,000 |
18 | remainder_NetIncome | -572,000 |
19 | remainder_ComprehensiveNetIncome | -27,000 |
yvar | yval | |
---|---|---|
0 | Assets | 185,921,000 |
1 | Liabilities | 38,338,000 |
2 | Expenses | 299,726,000 |
3 | Revenues | 275,706,000 |
4 | StockholdersEquity | 147,583,000 |
5 | NetIncome | -24,592,000 |
6 | ComprehensiveNetIncome | -24,619,000 |
7 | BaseVar | 400,145,000 |
8 | EconomicCapitalRatio | 3.44 |